Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

Anne S. Tsao, MD

Dr. Tsao
Houston, TX


Dr. Anne S. Tsao

Director, Department of Mesothelioma Program

The University of Texas MD Anderson Cancer Center

Thoracic Center
Main Building, Floor 9, near Elevator B
1515 Holcombe Boulevard
Houston, TX 77030

Need Help Contacting This Doctor?

As director of the mesothelioma program at the MD Anderson Cancer Center at the University of Texas in Houston, Anne Tsao, MD is one of the nation's foremost authorities on malignant mesothelioma.

Dr. Tsao and her colleagues at MD Anderson have penned many articles providing a large amount of information for many professional journals and have been involved in numerous clinical trials involving the treatment of malignant mesothelioma, an aggressive form of cancer that is often diagnosed in advanced stages and difficult to treat.

In articles in publications such as the Journal of Clinical Oncology, Tsao has discussed the impact of novel therapies, the importance of clinical trials, and controversial issues such as the use of extrapleural pneumonectomy in the treatment of the disease. She has also campaigned for the use of intrapleural therapies as well as gene therapy and immunotherapy for the treatment of malignant pleural mesothelioma and lectures nationally and internationally on these subjects.

Tsao has also performed studies involving smoking history and its impact on the prognosis of those with non-small cell lung cancers like mesothelioma. She has also stressed the need for chemo-prevention, the use of natural, synthetic, or biologic chemical agents to suppress cancer in high-risk populations or prevent carcinogenic progression to invasive cancer.

Main Specialty: Thoracic Medical Oncology

Other Interests & Specialties: Individualized cancer therapy, mesothelioma and lung cancer.

Certifications, Awards & Accolades: Co-Chair of the MDACC Clinical Research Committee, Scientific Advisory Committee member, chairing session participant for American Radium Society, Chair of the Communications Committee for International Association for the Study of Lung Cancer (IASLC), Chair of the Mesothelioma Applied Research Foundation (MARF), SWOG Executive Lung Committee member, SWOG Mesothelioma Steering Committee member, DSMB for NRG Thoracic Oncology member and NRG Lung Executive Committee member.

Education & Experience:

Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. September 2016. doi: 10.1200/JCO.2005.02.447

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). BioMed Central Ltd. in Head & Neck Oncology. June 2010;2(1):15. doi: 10.1186/1758-3284-2-1-15

Mesothelioma Clinical Trials by Anne S. Tsao, MD

Dr. Tsao is associated with the following clinical trials:

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois

Top Mesothelioma Doctors

Please fill in the form below to request help contacting a mesothelioma specialist. We will respond promptly to your inquiry.

Have you or someone you know been diagnosed with mesothelioma?

Connect With A Mesothelioma Specialist:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide